187 related articles for article (PubMed ID: 16803948)
1. Prognostic significance of CDC25B expression in gliomas.
Nakabayashi H; Hara M; Shimizu K
J Clin Pathol; 2006 Jul; 59(7):725-8. PubMed ID: 16803948
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
3. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma.
Wang M; Zhu XY; Wang L; Lin Y
Cancer Biother Radiopharm; 2015 Apr; 30(3):139-45. PubMed ID: 25775393
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
[TBL] [Abstract][Full Text] [Related]
7. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Bakhshi S; Chawla B; Kashyap S
Br J Ophthalmol; 2015 Apr; 99(4):457-63. PubMed ID: 25326518
[TBL] [Abstract][Full Text] [Related]
8. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of p42.3 in low- and high-grade gliomas.
Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
[TBL] [Abstract][Full Text] [Related]
10. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
11. CDC25B: relationship with angiogenesis and prognosis in non-small cell lung carcinoma.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Fontanini G
Hum Pathol; 2007 Oct; 38(10):1563-8. PubMed ID: 17651784
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
[TBL] [Abstract][Full Text] [Related]
13. CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas.
Suren D; Isiksacan Ozen O
J BUON; 2013; 18(4):1006-11. PubMed ID: 24344030
[TBL] [Abstract][Full Text] [Related]
14. Protein and mRNA levels of YKL-40 in high-grade glioma.
Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma.
Takemasa I; Yamamoto H; Sekimoto M; Ohue M; Noura S; Miyake Y; Matsumoto T; Aihara T; Tomita N; Tamaki Y; Sakita I; Kikkawa N; Matsuura N; Shiozaki H; Monden M
Cancer Res; 2000 Jun; 60(11):3043-50. PubMed ID: 10850455
[TBL] [Abstract][Full Text] [Related]
16. Caspase 8 is absent or low in many ex vivo gliomas.
Ashley DM; Riffkin CD; Muscat AM; Knight MJ; Kaye AH; Novak U; Hawkins CJ
Cancer; 2005 Oct; 104(7):1487-96. PubMed ID: 16080161
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance of cystatin C expression in gliomas.
Nakabayashi H; Hara M; Shimuzu K
Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
20. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
